Biotech
Stipple Bio Raises $100M to Advance Precision Cancer Therapy Into Clinic
Stipple Bio secures $100 million in Series A funding to advance its lead oncology asset STP-100 into clinical trials, focusing on precision cancer targeting.
S
Surya Pratap Singh
4/7/2026, 6:54:37 AM
